Overview

Multiple Treatments for Ebola Virus Disease (EVD)

Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether multiple therapeutic regimens are effective in the treatment of Ebola Virus Disease (EVD)
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Clinical Research Management, Inc.
Collaborators:
Bill and Melinda Gates Foundation
Duke University
INC Research
Syneos Health
University of North Carolina
University of Sierra Leone
Treatments:
Atorvastatin
Atorvastatin Calcium
Azithromycin
Erlotinib Hydrochloride
Irbesartan
Sunitinib